Carrillo MMG

Language: Spanish
References: 7
Page: 95-98
PDF size: 71.04 Kb.

ABSTRACT

The risk of transmission of infectious viral diseases by blood transfusion has diminished but it has not disappeared. Detection methods are focused in diseases, such as hepatitis B and C and HIV. However, there are new pathogen agents that can be transmitted by blood transfusion, such as the TT virus, that was isolated from a patient with post-transfusion acute hepatitis of unascertained etiology. The prevalence of this virus presents a wide variability (1-80 %). It is more frequent in patients who have had blood transfusions. Its transmission has been associated to chronic hepatic illnesses.

REFERENCES

1. Busch M, Kleinman S, Nemo G. Current and emerging infections risks of blood transfusions. JAMA 2003; 289 (8): 959-962.

2. Desai SM, Muerhoff AS, Leary TP, Erker JC, Simons JN, Chalmers ML, et al. Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis 1999; 180 (5): 1748-1750.

3. Bendinelli M, Pistello M, Maggi F, Fornai C, Freer G, Vatteroni M. Molecular properties, biology, and clinical implications of TT virus. A recently identified widespread infectious agent of humans. Clin Microbiol Rev 2001; 14 (1): 98-113.

4. Grabarczyk P, Brojer E. Polymorphism of the TT virus and its frequency in Polish blood donors. Vox Sang 2002; 82 (4): 177-181.

5. Okamoto H, Nishizawa T, Takahashi M. Torque teno virus (TTV): Molecular virology and clinical implications. Viral hepatitis 2004; 35 (6): 241-254.

6. Pisani G, Cristiano K, Wirz M, Bisso G, Beneduce F, Morace G et al. Prevalence of TT virus in plasma pools and blood products. Br J Haematol 1999; 106 (2): 431-435.

7. Naumov N, Petrova E, Thomas M, Williams R. Presence or a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998; 352 (18): 195-119.